- ►diabetesjournals.org CK Kramer, CB Leitão, LH Canani, JL Gross - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—Forty-six type 2 diabetic patients had WCH (14.4%; mean age 56.6
years; 45.3% men) and 117 had normotension (36.6%; mean age 55.8 years; 37.5%
men). These groups did not differ in clinical and main laboratory ... Cited by 5 - Related articles - All 3 versions
CB Leitão, LH Canani, CK Kramer, M … - Diabetic Medicine, 2008 - pt.wkhealth.com Results: UAER, after multivariate adjustments, was associated with office BP
(systolic: R 2 a 0.162, P < 0.001; diastolic: R 2 a 0.124, P < 0.001) and ABPM
(24-h systolic: R 2 a 0.195, P < 0.001; 24-h diastolic: R 2 a 0.197, P < ... Cited by 3 - Related articles - BL Direct - All 6 versions
JA McKnight - Diabetic Medicine, 2007 - ingentaconnect.com Hypothesis: the `metabolic memory', the new challenge of diabetes pp. 582-586(5)
Authors: Ihnat, MA; Thorpe, JE; Ceriello, A. ... Rosiglitazone RECORD study:
glucose control outcomes at 18 months pp. 626-634(9) Authors: Home, PD; ... Cited by 2 - Related articles - BL Direct - All 5 versions
AS Januszewski, MC Thomas, CS Karschimkus, … - The Journal of Medical Investigation, 2008 - medical.med.tokushima-u.ac.jp Advanced glycation-end products (AGEs) are a het- erogeneous group of
fluorescent and non-fluorescent compounds implicated in the pathogenesis of the
micro- and macro-vascular complications of diabe- Cited by 2 - Related articles - View as HTML - All 2 versions
EB Assayag, I Bova, A Kesler, S Berliner, I … - Disease Markers, 2008 - IOS Press Abstract. Background: Atherosclerosis is a chronic inflammatory disease. Design:
We have evaluated the degree of erythrocyte aggregation (EA) as a
microinflammatory biomarker in a cohort of hospital-based, neurologically ... Cited by 2 - Related articles - BL Direct - All 2 versions
G MB, N VG - DIABETES RESEARCH AND CLINICAL PRACTICE, 2004 - sid.ir 9 : DIABETES RESEARCH AND CLINICAL PRACTICE October 2004; 66(1):31-39.
ACUTE-PHASE PROTEINS AND MICROALBUMINURIA AMONG PATIENTS ... Cited by 2 - Cached
MB Gomes, RA Cobas, E Nunes, M Nery, HC … - Prostaglandins and Other Lipid Mediators, 2008 - Elsevier Plasma activity of the platelet-activating factor acetylhydrolase (PAF-AH) plays
an important role in inflammation and atherosclerotic process in chronic
diseases. We aimed to evaluate the levels of PAF-AH activity and their ... Cited by 2 - Related articles - All 2 versions
SH de Castro, HC Castro-Faria-Neto, MB … - The Review of Diabetic Studies, 2005 - pubmedcentral.nih.gov BACKGROUND: Cardiovascular disease is the main cause of death in patients with
type 1 diabetes. Since oxidized low density lipoprotein (LDL) is considered to
be a critical factor in the atherosclerotic process, the aim of our study ... Cited by 2 - Related articles - All 5 versions
K Eguchi, K Kario - Diabetes Care, 2009 - Am Diabetes Assoc In their recent study, Kramer et al. (1) performed a cross-sectional study
comparing type 2 diabetes with white-coat hypertension (WCH) and normotension
and showed that type 2 diabetic patients with WCH have an increased risk ... Cited by 1 - Related articles - All 3 versions
J Esteves, AF Laranjeira, MF Roggia, M … - Arquivos Brasileiros de Endocrinologia & Metabologia, 2008 - SciELO Brasil A retinopatia diabética (RD) acomete cerca de 95% dos pacientes com diabetes
melito tipo 1 (DM1) e 60% dos pacientes com diabetes melito tipo 2 (DM2), sendo
a principal causa de cegueira legal em adultos. O objetivo desse manuscrito ... Cited by 3 - Related articles - Cached - All 3 versions
